Multiplex Bead Array Assay of a Panel of Circulating Cytokines and Growth Factors in Patients with Albuminuric and Non-Albuminuric Diabetic Kidney Disease

Granulocyte Colony-Stimulating Factor Attenuates Renal Ischemia-Reperfusion Injury by Inducing Myeloid-Derived Suppressor Cells

(2020) Ji-Jing Yan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function

(2020) Liliane Silvano Araújo et al.   PLoS One

The Protective Effect of Basic Fibroblast Growth Factor on Diabetic Nephropathy Through Remodeling Metabolic Phenotype and Suppressing Oxidative Stress in Mice

(2020) Tingting Wei et al.   Frontiers in Pharmacology

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy

(2020) Sandra Rayego-Mateos et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Targeting the progression of chronic kidney disease

(2020) Marta Ruiz-Ortega et al.   Nature Reviews Nephrology

Renal structure in type 2 diabetes: facts and misconceptions

(2020) Angelo Di Vincenzo et al.   JOURNAL OF NEPHROLOGY

Renal expression of cytokines and chemokines in diabetic nephropathy

(2020) Liliane Silvano Araújo et al.   BMC Nephrology

Glucose Induces IL-1α-Dependent Inflammation and Extracellular Matrix Proteins Expression and Deposition in Renal Tubular Epithelial Cells in Diabetic Kidney Disease

(2020) Talal Salti et al.   Frontiers in Immunology

Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines

(2020) Isabel B. Pfister et al.   Translational Vision Science & Technology

Interleukin 17A promotes diabetic kidney injury

(2019) Jin Ma et al.   Scientific Reports

Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

(2019) Hiddo J. L. Heerspink et al.   DIABETOLOGIA

A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes

(2019) Monika A. Niewczas et al.   NATURE MEDICINE

High-fat diet-induced obesity causes an inflammatory microenvironment in the kidneys of aging Long-Evans rats

(2019) Thea Laurentius et al.   Journal of Inflammation-London

Histologic predictors of renal outcome in diabetic nephropathy

(2019) Gabriel Stefan et al.   MEDICINE

Macrophage phenotype and its relationship with renal function in human diabetic nephropathy

(2019) Xiaoliang Zhang et al.   PLoS One

Association of diabetes-related kidney disease with cardiovascular and non-cardiovascular outcomes: a retrospective cohort study

(2019) James B. Wetmore et al.   BMC Endocrine Disorders

The new biology of diabetic kidney disease - mechanisms and therapeutic implications

(2019) Yuliya Lytvyn et al.   ENDOCRINE REVIEWS

Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes

(2019) Habib Yaribeygi et al.   LIFE SCIENCES

Recombinant human GLP-1(rhGLP-1) alleviating renal tubulointestitial injury in diabetic STZ-induced rats

(2018) Weiqin Yin et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

M1/M2 macrophages in diabetic nephropathy: Nrf2/HO-1 as therapeutic targets

(2018) R. Clive Landis et al.   CURRENT PHARMACEUTICAL DESIGN

All-trans retinoic acid ameliorates inflammatory response mediated by TLR4/NF-кB during initiation of diabetic nephropathy

(2018) Edith Sierra-Mondragon et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice

(2018) Rui Wu et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Intrarenal delivery of bFGF-loaded liposome under guiding of ultrasound-targeted microbubble destruction prevent diabetic nephropathy through inhibition of inflammation

(2018) Wen-Shuang Sheng et al.   Artificial Cells Nanomedicine and Biotechnology

Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines

(2018) Irene Maeve Rea et al.   Frontiers in Immunology

Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways

(2018) Habib Yaribeygi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Renoprotection of dapagliflozin in human renal proximal tubular cells via the inhibition of the high mobility group box 1‑receptor for advanced glycation end products‑nuclear factor‑κB signaling pathway

(2018) Di Yao et al.   Molecular Medicine Reports

Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome

(2018) Simona Mihai et al.   Journal of Immunology Research

Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals

(2018) Francesca Viazzi et al.   JOURNAL OF NEPHROLOGY

Eosinophilia and Kidney Disease: More than Just an Incidental Finding?

(2018) Philipp Gauckler et al.   Journal of Clinical Medicine

Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1

(2018) Aya Aly A. El-Shazly et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

VEGF and the diabetic kidney: More than too much of a good thing

(2017) Syamantak Majumder et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Potential association between elevated serum human epididymis protein 4 and renal fibrosis

(2017) Peipei Chen et al.   MEDICINE

IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy

(2017) Huey-Liang Kuo et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The role of interleukin-17A in the pathogenesis of kidney diseases

(2017) Charlotte Cortvrindt et al.   PATHOLOGY

Inflammatory Cytokines as Uremic Toxins: “Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son”

(2017) Esmeralda Castillo-Rodríguez et al.   Toxins

Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells

(2017) Jui-Ting Chang et al.   BMC Pharmacology & Toxicology

Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update

(2017) Hua Su et al.   Frontiers in Immunology

Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models

(2016) Yusuke Wada et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II–Induced HypertensionNovelty and Significance

(2016) Allison E. Norlander et al.   HYPERTENSION

Macrophages in diabetic nephropathy in patients with type 2 diabetes

(2016) Celine Q.F. Klessens et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease

(2016) Jianxin Wan et al.   Oncotarget

Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy

(2016) Shuhua Lin et al.   MEDICAL SCIENCE MONITOR

Update on Inflammation in Chronic Kidney Disease

(2015) Oleh M. Akchurin et al.   BLOOD PURIFICATION

Vascular growth factors play critical roles in kidney glomeruli

(2015) L. Gnudi et al.   CLINICAL SCIENCE

Association between the IL17RA rs4819554 polymorphism and reduced renal filtration rate in the Spanish RENASTUR cohort

(2015) Eliecer Coto et al.   HUMAN IMMUNOLOGY

Local immunotherapy via delivery of interleukin-10 and transforming growth factor β antagonist for treatment of chronic kidney disease

(2015) Christopher B. Rodell et al.   JOURNAL OF CONTROLLED RELEASE

Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis

(2015) R. Mohamed et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease

(2015) V. I. Konenkov et al.   TERAPEVTICHESKII ARKHIV

Inflammatory Cytokines in Diabetic Nephropathy

(2015) Javier Donate-Correa et al.   Journal of Diabetes Research

Eotaxin-1 (CCL11)

(2015) Timothy John Williams   Frontiers in Immunology

Nephro-protective effect of granulocyte colony-stimulating factor in streptozotocin induced diabetic rats

(2014) O Erbas et al.   BIOTECHNIC & HISTOCHEMISTRY

Macrophage Trafficking as Key Mediator of Adenine-Induced Kidney Injury

(2014) Matheus Correa-Costa et al.   MEDIATORS OF INFLAMMATION

Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study

(2014) G. Pugliese et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function

(2013) E. I. Ekinci et al.   DIABETES CARE

Immunotherapy with injectable hydrogels to treat obstructive nephropathy

(2013) Danielle E. Soranno et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model

(2013) Yuanmeng Jin et al.   LABORATORY INVESTIGATION

Leukocyte Proliferation and Immune Modulator Production in Patients with Chronic Kidney Disease

(2013) Ladan Mansouri et al.   PLoS One

G-CSF Prevents Progression of Diabetic Nephropathy in Rat

(2013) Byung-Im So et al.   PLoS One

The Renal Endothelium in Diabetic Nephropathy

(2013) Theodoros Eleftheriadis et al.   RENAL FAILURE

Rapid Progression of Diabetic Nephropathy Is Linked to Inflammation and Episodes of Acute Renal Failure

(2010) K.J. Kelly et al.   AMERICAN JOURNAL OF NEPHROLOGY

Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy

(2010) Chia-Chao Wu et al.   CLINICA CHIMICA ACTA

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007

(2008) P. Fioretto et al.   DIABETOLOGIA

The Role of chemokines and chemokine receptors in diabetic nephropathy

(2007) Christiane Ruster   Frontiers in Bioscience-Landmark

Cellular and molecular mechanisms of fibrosis

(2007) TA Wynn   JOURNAL OF PATHOLOGY